AMN Healthcare price target raised to $110 from $105 at Truist

Truist raised the firm’s price target on AMN Healthcare to $110 from $105 and keeps a Buy rating on the shares. The company’s softer than expected Q3 revenue guidance was not surprising after the outlook from its peers, the analyst tells investors in a research note. AMN management has also noted strong winter orders and the current demand pipeline indicating that Nurse & Allied revenues could grow sequentially in Q4, the firm adds.